1.上海中医药大学附属曙光医院(上海 200021)
吴辰恒,女,硕士研究生,主要从事脾胃病的中医药诊疗研究工作
凌江红,教授,博士研究生导师; E-mail:459183870@qq.com
扫 描 看 全 文
吴辰恒,丛军,贾庆玲,等.蔡淦治疗慢性萎缩性胃炎临床疗效的真实世界研究[J].上海中医药杂志,2022,56(11):58-62.
WU Chenheng,CONG Jun,JIA Qingling,et al.Clinical efficacy of Cai Gan’s treatment of chronic atrophic gastritis: a real world study[J].Shanghai Journal of Traditional Chinese Medicine,2022,56(11):58-62.
吴辰恒,丛军,贾庆玲,等.蔡淦治疗慢性萎缩性胃炎临床疗效的真实世界研究[J].上海中医药杂志,2022,56(11):58-62. DOI: 10.16305/j.1007-1334.2022.2206082.
WU Chenheng,CONG Jun,JIA Qingling,et al.Clinical efficacy of Cai Gan’s treatment of chronic atrophic gastritis: a real world study[J].Shanghai Journal of Traditional Chinese Medicine,2022,56(11):58-62. DOI: 10.16305/j.1007-1334.2022.2206082.
目的,2,评价真实世界中蔡淦教授治疗慢性萎缩性胃炎(CAG)的疗效和安全性。,方法,2,选取316例CAG患者,均接受蔡淦教授中药处方(新胃方为主)治疗,疗程至少6个月。观察治疗2周、治疗4周时的中医症状疗效及治疗6个月时的胃镜病理疗效,比较治疗前与治疗2周、治疗4周时自评结局量表(MYMOP2),焦虑自评量表(SAS),抑郁自评量表(SDS)评分的变化情况,同时进行安全性评价。,结果,2,①治疗2周、治疗4周时的中医症状总有效率分别为95.8%、99.4%;治疗4周时的中医症状疗效优于治疗2周时,差异有统计学意义(,P,<,0.05)。②与治疗前比较,治疗2周、治疗4周时的MYMOP2、SAS、SDS评分降低(,P,<,0.05);与治疗2周时比较,治疗4周时MYMOP2、SAS、SDS评分降低(,P,<,0.05)。③治疗6个月后,病理萎缩、肠上皮化生及胃镜病理总体有效率分别为54.8%、74.0%、71.2%。④治疗过程中,无不良反应发生,血常规、肝肾功能无明显变化。,结论,2,真实世界中蔡淦教授治疗CAG疗效满意,能显著缓解患者的消化不良症状;随着治疗时间的延长,能有效改善CAG患者胃组织病理萎缩和肠上皮化生,且安全性良好。
Objective,2,To evaluate the efficacy and safety of Prof. Cai Gan’s treatment of chronic atrophic gastritis (CAG) in the real world.,Methods,2,A total of 316 patients with CAG received Prof. Cai Gan’s traditional Chinese medicine (TCM) treatment (mainly based on Xinwei Decoction)for at least 6 months. TCM symptom scores after 2 and 4 weeks of treatment, as well as gastroscopy and gastric mucosa histopathology after 6 months of treatment were observed; the scores of MYMOP2, SAS and SDS before treatment were compared with those after 2 and 4 weeks of treatment, respectively; and the safety evaluation was also performed.,Results,2,①The total effective rate of TCM symptom was 95.8% after 2 weeks of treatment and reached 99.4% after 4 weeks of treatment. The improvement of TCM symptoms after 4 weeks of treatment was better than that after 2 weeks of treatment, and the difference was statistically significant (,P,<,0.05). ②The scores of MYMOP2, SAS and SDS were lower after 2 and 4 weeks of treatment than those before treatment (,P,<,0.05); The scores of MYMOP2, SAS and SDS after 4 weeks of treatment were lower than those after 2 weeks of treatment (,P,<,0.05). ③After 6 months of treatment, the gastroscopic pathological effective rate reached 71.2%, the total effective rate of pathological atrophy reached 54.8%, and that of pathological intestinal metaplasia reached 74.0%. ④No adverse reactions occurred during the treatment. There were no significant changes in the routine blood test, and the liver and kidney function test.,Conclusion,2,In the real world, Prof. Cai Gan has achieved a satisfactory result in the treatment of CAG, as his therapy can significantly alleviate the indigestion symptoms of patients, effectively improve the pathological atrophy of gastric tissue and intestinal metaplasia in CAG patients with the prolongation of treatment, and simultaneously have good long-term safety.
慢性萎缩性胃炎中医药疗法名医经验病理真实世界研究
chronic atrophic gastritistraditional Chinese medicine therapyfamous doctor’s experiencepathologyreal world study
中国中西医结合学会消化系统疾病专业委员会. 慢性萎缩性胃炎中西医结合诊疗共识意见(2017年)[J]. 中国中西医结合消化杂志,2018, 26(2): 121-131.
DUXON M F, GENTA R M, YARDLEY J H, et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994[J]. Am J Surg Pathol, 1996, 20(10): 1161-1181.
袁成业,肖建国,陈林伟,等. 慢性萎缩性胃炎中医诊治难点分析及对策[J]. 中华中医药杂志,2021, 36(1): 292-295.
王晓楠,张亚峰,许翠萍. 慢性萎缩性胃炎的诊治进展[J]. 中南医学科学杂志,2020, 48(3): 323-326.
刘晓谷,蔡淦. 蔡淦辨治慢性萎缩性胃炎经验[J]. 上海中医药杂志,2009, 43(7): 5-7.
张正利. 蔡淦治疗慢性胃炎经验[J]. 中医杂志,2009, 50(11): 975-976.
王松坡. 蔡淦教授论治胃癌前病变的经验[J]. 辽宁中医杂志,1999, 26(1): 10.
朱梅萍,张正利,林江. 蔡淦治疗慢性胃炎的临床经验[J]. 上海中医药杂志,2006, 40(7): 12-13.
崔儒涛. 蔡淦逆转胃癌前病变的经验[J]. 中医杂志,1999, 40(7): 398-399.
许雷,蔡淦. 蔡淦运用东垣元气阴火学说论治慢性萎缩性胃炎经验[J]. 四川中医,2014, 32(4): 11-12.
郑亚江,马赵青,洪蔚蔚,等. 蔡淦教授从肝论治脾胃病的临证经验[J]. 现代中西医结合杂志,2018, 27(22): 2436-2439.
施慧婷,张正利,朱梅萍,等. 基于数据挖掘的蔡淦教授诊治131例慢性胃炎辨证及用药经验研究[J]. 江苏中医药,2016, 48(6): 38-40.
中华医学会消化病学分会. 中国慢性胃炎共识意见(2017年,上海)[J]. 胃肠病学,2017, 22(11): 670-687.
中华中医药学会脾胃病分会. 慢性胃炎中医诊疗专家共识意见(2017)[J]. 中华中医药杂志,2017, 32(7): 3060-3064.
赵金铎,张镜人,张震,等. 中医症状鉴别诊断学[M]. 北京:人民卫生出版社,1983: 3.
中国中西医结合学会消化系统疾病专业委员会. 胃肠疾病中医症状评分表[J]. 中国中西医结合消化杂志,2011, 19(1): 66-68.
吕美君,张会永,陈智慧,等. 基于MYMOP探讨以患者主诉症状为主体的中医证候疗效评价方法构建[J]. 中华中医药学刊,2020, 38(2): 62-64.
段泉泉,胜利. 焦虑及抑郁自评量表的临床效度[J]. 中国心理卫生杂志,2012, 26(9): 676-679.
周建中,陈泽民,危北海. 慢性胃炎中西医结合诊断、辨证和疗效标准(试行方案)[J]. 中国中西医结合杂志,1990, 10(5): 318-319.
蔡淦,林江,丛军,等. 蔡淦治疗脾胃病临证经验医案集要[M]. 北京:科学出版社,2019: 11.
于河,鲜馥阳,费宇彤,等. 开展真实世界名老中医经验传承病例系列研究方法要点[J]. 中华中医药杂志,2021, 36(8): 4451-4455.
陈薇,陈可冀,刘建平. 中医药真实世界研究证据的构成及分级标准建议[J]. 中国中西医结合杂志,2021, 41(5): 608-611.
董智平,张静喆. 中医治疗胃癌研究进展[J]. 中国中西医结合外科杂志,2019, 25(2): 206-209.
张国新,党旖旎,严谨. 胃癌前病变的治疗[J]. 医学与哲学(B),2015, 36(11): 19-21,87.
王伽伯,宋海波,宁可永. 中药安全性评价的挑战与思考[J]. 药物不良反应杂志,2018, 20(6): 409-412.
0
浏览量
448
下载量
0
CSCD
2
CNKI被引量
关联资源
相关文章
相关作者
相关机构